sector: Healthcare ·
industry: Pharmaceuticals - Generic & Specialty ·
As of
26 Nov 2009
15.00CAD
$15.00
26 Nov 2009
-0.20%
$15.03
$15.00
181,502
$15.08
$14.90
$16.59
$9.77
0.45
748,273
News
Key Developments
Officers
| Name |
Current Position |
Compensation |
| Squires, Douglas |
Chairman of the Board |
4,574,620 |
| Wells, William |
Chief Executive Officer, Director |
4,331,580 |
| Mulligan, Margaret |
Chief Financial Officer, Senior Vice President |
347,086 |
Key Ratios and Statistics
| Share Related Items |
| Market Cap (Mil.) |
$2,378.83 |
| Shares Outstanding (Mil.) |
158.27 |
| Float (Mil.) |
137.60 |
| |
| Dividend Information |
| Yield % |
-- |
| Annual Dividend ($ CAD) |
1.58 |
| Payout Ratio(TTM) % |
65.77 |
| |
| Financial Strength |
| Quick Ratio |
1.61 |
| Current Ratio |
1.14 |
| LT Debt/Equity |
28.38 |
| Total Debt/Equity |
29.30 |
| |
| Valuation Ratios |
| Price/Earnings(TTM) |
10.12 |
| Price/Sales(TTM) |
2.97 |
| Price/Book(TTM) |
1.75 |
| Price/Cash Flow(TTM) |
6.35 |
| |
|
| Per Share Data |
| Earnings(TTM) |
$1.49 |
| Sales(TTM) |
$5.05 |
| Book Value(MRQ) |
$8.58 |
| Cash Flow(TTM) |
$2.36 |
| Cash(MRQ) |
$0.37 |
|
| Management Effectiveness |
| Return on Equity(TTM) |
18.23 |
| Return on Assets(TTM) |
12.71 |
| Return on Investment(TTM) |
14.43 |
| |
|
| Margins |
| Gross Margin(TTM) % |
73.47 |
| Operating Margin(TTM) % |
19.73 |
| Profit Margin(TTM) % |
29.42 |
|
| |
|